Charles A McWherter Selected Research

Charles A McWherter Research Topics

3	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2022 - 10/2017
3	Pruritus (Itching) 01/2022 - 10/2017
2	Gout 01/2017 - 01/2016
1	Cholestasis 01/2022
1	Disease Progression 01/2022
1	Fatigue 01/2022
1	Inflammation (Inflammations) 01/2022
1	Nausea 10/2017
1	Spasm (Spasms) 10/2017
1	Myalgia 10/2017
1	Dizziness (Lightheadedness) 10/2017
1	Dyspepsia (Indigestion) 10/2017
1	Non-alcoholic Fatty Liver Disease 01/2017
1	Body Weight (Weight, Body) 01/2017
1	Hyperglycemia 01/2017
1	Hyperinsulinism (Hyperinsulinemia) 01/2017
1	Insulin Resistance 01/2017
1	Weight Loss (Weight Reduction) 01/2017
1	Hyperuricemia 01/2017
1	Dyslipidemias (Dyslipidemia) 01/2017
1	Urinary Calculi (Urinary Calculus) 01/2016

4	seladelparIBA 01/2022 - 01/2017
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2022 - 10/2017
2	PPAR deltaIBA 01/2022 - 01/2017
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2017 - 01/2017
2	Uric Acid (Urate)IBA 01/2017 - 01/2016
2	arhalofenateIBA 01/2017 - 01/2016
1	Bile Acids and Salts (Bile Acids)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Alkaline PhosphataseIBA 01/2022
1	(2- methyl- 4- (5- methyl- 2- (4- trifluoromethyl- phenyl)- 2H- (1,2,3)triazol- 4- ylmethylsulfanyl)phenoxy)acetic acidIBA 01/2017
1	Febuxostat FDA Link 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2017
1	LipidsIBA 01/2017
1	PPAR alphaIBA 01/2017
1	Allopurinol (Remid)FDA LinkGeneric 01/2016
1	Colchicine FDA LinkGeneric 01/2016

3	Therapeutics 10/2017 - 01/2016